Premium
SCN2A Mutations and Benign Familial Neonatal‐Infantile Seizures: The Phenotypic Spectrum
Author(s) -
Herlenius Eric,
Heron Sarah E.,
Grinton Bronwyn E.,
Keay Deborah,
Scheffer Ingrid E.,
Mulley John C.,
Berkovic Samuel F.
Publication year - 2007
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/j.1528-1167.2007.01049.x
Subject(s) - phenocopy , mutation , etiology , phenotype , genetics , medicine , epilepsy , pediatrics , age of onset , biology , gene , disease , psychiatry
Summary: Mutations of the sodium channel subunit gene SCN2A have been described in families with benign familial neonatal‐infantile seizure (BFNIS). We describe two large families with BFNIS and novel SCN2A mutations. The families had 12 and 9 affected individuals, respectively, with phenotypes consistent with BFNIS. Two mutations were discovered in SCN2A (E430Q; I1596S). Both families had individuals with neonatal onset but the typical age of onset was in the early infantile period (mean 3.0 months). One mutation positive individual, with an otherwise typical clinical pattern, had seizures beginning at 13 months. Two individuals with SCN2A mutations were identified with seizures in later life. In each family a single individual with infantile seizures was mutation negative and thus represented phenocopies. This study extends the age range of presentation of BFNIS, confirms that neonatal and early infantile onsets are characteristic, and emphasizes the role of molecular diagnosis to confirm the etiology.